Mycophenolate mofetil-based salvage as acute GVHD prophylaxis after early discontinuation of tacrolimus and/or sirolimus

Bone Marrow Transplant. 2015 Feb;50(2):307-9. doi: 10.1038/bmt.2014.245. Epub 2014 Nov 3.

Authors

H Ali¹, J Palmer², Z Eroglu¹, T Stiller², S H Thomas¹, S Khaled¹, S Shayani³, P Parker¹, S J Forman¹, R Nakamura¹

Affiliations

¹ Department of Hematology/Hematopoietic Cell Transplantation, City of Hope, Duarte, CA, USA.
² Department of Biostatistics, City of Hope, Duarte, CA, USA.
³ Department of Pharmacy, City of Hope, Duarte, CA, USA.

No abstract available

Publication types

Letter
Research Support, N.I.H., Extramural

MeSH terms

Acute Disease
Adult
Aged
Allografts
Disease-Free Survival
Female
Graft vs Host Disease / mortality*
Graft vs Host Disease / prevention & control*
Hematologic Neoplasms / mortality
Hematologic Neoplasms / therapy
Hematopoietic Stem Cell Transplantation*
Humans
Immunosuppressive Agents / administration & dosage*
Male
Middle Aged
Mycophenolic Acid / administration & dosage
Mycophenolic Acid / analogs & derivatives*
Retrospective Studies
Sirolimus / administration & dosage*
Survival Rate
Tacrolimus / administration & dosage*

Substances

Immunosuppressive Agents
Mycophenolic Acid
Sirolimus
Tacrolimus

Grants and funding